Julia Y. Tsang - Concepedia

Author

Julia Y. Tsang

Also Known As

J Tsang, J. Tsang, J.-S Tsang, J.Y.S Tsang, J.Y.S. Tsang, Josephine D. Tsang, Josephine Tsang, Julia Tsang, Julia Y S Tsang, Julia Y Tsang

139

Publications

4.7K

Citations

H-Index

Concepts

All Affiliations

Chinese University of Hong Kong Prince of Wales Hospital Kwong Wah Hospital Tuen Mun Hospital Singapore General Hospital

About

Julia Y. Tsang is an author at Chinese University of Hong Kong specializing in medicine, breast cancer, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	36	2K
2	Cell Biology	17	22	959
3	Health Sciences	4	4	144
4	Engineering	1	1	39
5	Allergy	1	1	18

Julia Y. Tsang

Publications

3.7K

Citations

H-Index

Page 1

	Year	Citations
Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria Sandra C. Kim, Susan L. Tonkonogy, Carol A. Albright, Gastroenterology DysbiosisMucosal ImmunologyPathogenesisImmunologyVariable Phenotypes	2005	428
In vitro–expanded donor alloantigen–specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance Déla Golshayan, Shuiping Jiang, Julia Y. Tsang, Blood	2006	307
CD73 expression on extracellular vesicles derived from CD4<sup>+</sup>CD25<sup>+</sup>Foxp3<sup>+</sup> T cells contributes to their regulatory function Lesley A. Smyth, Kulachelvy Ratnasothy, Julia Y. Tsang, European Journal of Immunology Adenosine ReceptorsT-regulatory CellImmunologyImmune RegulationRegulatory T Cells	2013	252
Antigen presentation by mouse CD4+ T cells involving acquired MHC class II:peptide complexes: another mechanism to limit clonal expansion? Julia Y. Tsang, Jian Guo Chai, Robert I. Lechler Blood	2003	115
Keratin expression in breast cancers Mumin Shao, Siu Ki Chan, Alex M C Yu, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin Breast OncologyBreast CancerKeratin ExpressionMedicineRadiation Oncology	2012	114
The maintenance of human CD4+CD25+ regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro J. Yates, Flavia Rovis, Peter Mitchell, International Immunology	2007	113
PD-L1 expression and tumor infiltrating PD-1+ lymphocytes associated with outcome in HER2+ breast cancer patients Julia Y. Tsang, W AU, Kwan-Yin Lo, Breast Cancer Research and Treatment Breast OncologyCancer ImmunosurveillancePd-l1 ExpressionMedicineImmunology	2017	108
Distinct Tertiary Lymphoid Structure Associations and Their Prognostic Relevance in HER2 Positive and Negative Breast Cancers Xia Liu, Julia Y. Tsang, Thazin Hlaing, The Oncologist	2017	101
Cancer stem cell markers are associated with adverse biomarker profiles and molecular subtypes of breast cancer Julia Y. Tsang, Yuhua Huang, Minghua Luo, Breast Cancer Research and Treatment Breast OncologyMolecular SubtypesMedicinePathologyCancer Genomics	2012	76
Androgen Receptor Expression Shows Distinctive Significance in ER Positive and Negative Breast Cancers Julia Y. Tsang, Yun‐Bi Ni, Siu‐Ki Chan, Annals of Surgical Oncology Negative Breast CancersBreast OncologyMedicineHormonal ReceptorPathology	2014	74

Page 1